BATS.L vs. AZN
BATS.L (British American Tobacco plc) and AZN (AstraZeneca PLC) are both stocks. BATS.L operates in Tobacco (Consumer Defensive), while AZN operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, BATS.L returned 7.31%/yr vs 16.63%/yr for AZN. At a 0.29 correlation, their price movements are largely independent.
Performance
BATS.L vs. AZN - Performance Comparison
Loading charts...
Different Trading Currencies
BATS.L is traded in GBp, while AZN is traded in USD. To make them comparable, the AZN values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, BATS.L achieves a 7.56% return, which is significantly higher than AZN's 1.79% return. Over the past 10 years, BATS.L has underperformed AZN with an annualized return of 7.31%, while AZN has yielded a comparatively higher 16.63% annualized return.
BATS.L
- 1D
- 1.48%
- 1M
- 4.73%
- YTD
- 7.56%
- 6M
- 6.51%
- 1Y
- 34.97%
- 3Y*
- 29.92%
- 5Y*
- 18.46%
- 10Y*
- 7.31%
AZN
- 1D
- -2.40%
- 1M
- 1.44%
- YTD
- 1.79%
- 6M
- 1.36%
- 1Y
- 29.80%
- 3Y*
- 7.39%
- 5Y*
- 13.34%
- 10Y*
- 16.63%
BATS.L vs. AZN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BATS.L British American Tobacco plc | 7.56% | 56.35% | 37.24% | -23.51% | 28.17% | 9.10% | -9.61% | 38.29% | -47.15% | 13.39% |
AZN AstraZeneca PLC | 1.79% | 33.09% | 1.12% | -3.63% | 33.30% | 20.79% | 0.09% | 30.52% | 20.61% | 21.59% |
Correlation
The correlation between BATS.L and AZN is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.24 |
Correlation (All Time) Calculated using the full available price history since Jul 5, 2007 | 0.29 |
The correlation between BATS.L and AZN shifts across timeframes, from 0.16 (3 years) to 0.29 (all time), reflecting how their relationship changes across market environments.
Fundamentals
BATS.L:
£97.89B
AZN:
$283.40B
BATS.L:
£4.91
AZN:
$6.66
BATS.L:
9.10
AZN:
27.27
BATS.L:
0.34
AZN:
0.04
BATS.L:
1.91
AZN:
4.69
BATS.L:
2.04
AZN:
5.99
BATS.L:
£51.48B
AZN:
$60.44B
BATS.L:
£35.04B
AZN:
$49.37B
BATS.L:
£17.11B
AZN:
$20.47B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BATS.L vs. AZN — Risk / Return Rank
BATS.L
AZN
BATS.L vs. AZN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for British American Tobacco plc (BATS.L) and AstraZeneca PLC (AZN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BATS.L | AZN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.32 | ||
| Sortino ratioReturn per unit of downside risk | +0.18 | ||
| Omega ratioGain probability vs. loss probability | 1.25 | 1.23 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | 2.54 | 2.00 | +0.54 |
| Martin ratioReturn relative to average drawdown | 6.13 | 5.24 | +0.89 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BATS.L | AZN | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.53 | 1.21 | +0.32 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.90 | 0.58 | +0.32 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.31 | 0.67 | -0.37 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.41 | 0.54 | -0.13 |
Drawdowns
BATS.L vs. AZN - Drawdown Comparison
The maximum BATS.L drawdown since its inception was -54.44%, which is greater than AZN's maximum drawdown of -32.75%. Use the drawdown chart below to compare losses from any high point for BATS.L and AZN.
Loading charts...
Drawdown Indicators
| BATS.L | AZN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -54.44% | -32.75% | -21.69% |
Max Drawdown (1Y)Largest decline over 1 year | -13.70% | -15.03% | +1.33% |
Max Drawdown (3Y)Largest decline over 3 years | -14.78% | -25.73% | +10.95% |
Max Drawdown (5Y)Largest decline over 5 years | -29.68% | -25.73% | -3.95% |
Max Drawdown (10Y)Largest decline over 10 years | -54.44% | -28.56% | -25.88% |
Current DrawdownCurrent decline from peak | -9.94% | -12.00% | +2.06% |
Average DrawdownAverage peak-to-trough decline | -15.17% | -8.23% | -6.94% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.69% | 5.71% | -0.02% |
Volatility
BATS.L vs. AZN - Volatility Comparison
British American Tobacco plc (BATS.L) has a higher volatility of 10.04% compared to AstraZeneca PLC (AZN) at 7.38%. This indicates that BATS.L's price experiences larger fluctuations and is considered to be riskier than AZN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BATS.L | AZN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.04% | 7.38% | +2.66% |
Volatility (6M)Calculated over the trailing 6-month period | 18.26% | 17.33% | +0.93% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.75% | 24.85% | -2.10% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.57% | 23.13% | -2.56% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.92% | 24.90% | -0.98% |
Dividends
BATS.L vs. AZN - Dividend Comparison
BATS.L's dividend yield for the trailing twelve months is around 5.40%, more than AZN's 2.93% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AZN AstraZeneca PLC | 2.93% | 1.70% | 2.27% | 2.15% | 2.12% | 2.35% | 2.80% | 2.81% | 3.69% | 3.95% | 5.01% | 4.06% |
BATS.L British American Tobacco plc | 5.40% | 5.70% | 8.18% | 10.06% | 6.64% | 7.89% | 7.77% | 6.28% | 7.81% | 4.35% | 0.00% | 0.00% |
Financials
BATS.L vs. AZN - Financials Comparison
This section allows you to compare key financial metrics between British American Tobacco plc and AstraZeneca PLC. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BATS.L vs. AZN - Profitability Comparison
BATS.L - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, British American Tobacco plc reported a gross profit of 8.28B and revenue of 13.54B. Therefore, the gross margin over that period was 61.1%.
AZN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a gross profit of 12.61B and revenue of 15.29B. Therefore, the gross margin over that period was 82.5%.
BATS.L - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, British American Tobacco plc reported an operating income of 5.02B and revenue of 13.54B, resulting in an operating margin of 37.1%.
AZN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported an operating income of 4.25B and revenue of 15.29B, resulting in an operating margin of 27.8%.
BATS.L - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, British American Tobacco plc reported a net income of 3.25B and revenue of 13.54B, resulting in a net margin of 24.0%.
AZN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, AstraZeneca PLC reported a net income of 3.08B and revenue of 15.29B, resulting in a net margin of 20.2%.
Frequently Asked Questions
BATS.L and AZN have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for BATS.L and AZN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer